当講座 友成 哲 助教による原著論文2編が、JGH OpenとHEPATOROGY RESEACH2誌でWILEY Top Cited Article 2021-2022を受賞する快挙を達成しました。
【受賞論文】
WILEY Top Cited Article 2021-2022, JGH OPEN
Tomonari T, Sato Y, Tanaka H, Mitsuhashi T, Hirao A, Tanaka T, Taniguchi T, Okamoto K, Sogabe M, Miyamoto H, Muguruma N, Takayama T.
Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma.
JGH Open. 2021; 5(11):1275-1283
Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma.
JGH Open. 2021; 5(11):1275-1283
WILEY Top Cited Article 2021-2022, HEPATOLOGY RESEARCH
Tomonari T, Sato Y, Tani J, Hirose A, Ogawa C, Morishita A, Tanaka H, Tanaka T, Taniguchi T, Okamoto K, Sogabe M, Miyamoto H, Muguruma N, Uchida K, Masaki T, Takayama T.
Comparison of therapeutic outcomes of Sorafenib and Lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular-targeted agent sequential therapy: A propensity score-matched analysis.
Hepatology Research. 2021; 51(4): 472-481
Comparison of therapeutic outcomes of Sorafenib and Lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular-targeted agent sequential therapy: A propensity score-matched analysis.
Hepatology Research. 2021; 51(4): 472-481